Who We Are

Lamark Biotech Pvt. Ltd. is a biotechnology company focusing on the Research and Development of Thermostable biologics (refrigeration independent). The company has a team of experienced scientists from India, Europe, and the United States at its core, who collectively have more than 150 high-quality publications and multiple patents. The company was founded in India in 2018 and was established in Genopole, Paris, France in the year 2021.

Our Vision

Molecular medicine, i.e., therapeutic proteins, gene therapies, and cell therapies, have progressed exponentially in the last two decades. However, most do not support a sustainable model for healthcare, and the majority of patients in the developing world could not afford them. Our vision is to improve the affordability and accessibility of essential modern medicines by developing innovative scientific solutions that can promote sustainable business strategies and pricing models.

Our MISSION

Cold chain dependence limits the accessibility of proteins and substantially alleviates the cost of logistics and storage. Further, it is an extra variable for pharma companies, which is difficult to manage during quality control procedures. Our first mission is to reduce the dependence of protein biologics on the cold chain for transportation and storage. This will comfortably bring down the cost by 20 percent and significantly increase the accessibility and ease of logistics in developing nations.

Formulating Hope: The Journey of a Life-Saving Molecule

Imagine a molecule – small, invisible to the naked eye, yet carrying the power to save lives. It could be insulin for someone struggling with diabetes. Or a monoclonal antibody offering hope in the fight against cancer. Or a vaccine, protecting entire communities from deadly outbreaks.

But this molecule didn’t just appear overnight. Its journey began years ago, in a lab filled with ambition and uncertainty. Some of the world’s brightest scientists and healthcare experts poured their time, intellect, and passion into its discovery. Out of millions of possibilities, this one molecule showed promise. It survived rounds of experiments, peer reviews, sleepless nights, failed attempts—and still, it held on. At last, it proved it could do something extraordinary: it could heal. But this is only the beginning.

Before this molecule could reach a patient – and truly care for someone – it needed to be cared for itself, a short but indispensable step in the life journey is called formulation. Think of formulation as “building a nest”. Like a mother’s embrace, formulation protects the molecule from the harsh realities of the outside world – extreme temperatures, light, movement, time. It ensures the molecule stays stable, effective, and ready to work, whether it’s traveling thousands of miles from a manufacturing site or navigating the complexities of the human body. Without the right formulation, even the most miraculous molecule can falter. It may lose its potency. It may become too fragile to transport. It may demand refrigeration, difficult storage, or painful delivery methods – barriers that ultimately mean fewer patients benefit from its potential.

Lamark was founded to give these molecules the care they need. Through the science of formulation, advanced analytics, and smart innovation, we build technologies that make biologics stronger, more stable, and easier to deliver. Eye drops, long-acting injectables, thermostable biosimilars – these are just some of the ways we help life-saving molecules fulfill their promise of Healthcare.

Our work spans diabetes, ophthalmology, and oncology. We collaborate with global teams and public institutions for one mission: To care for medicines – so they can care for us.

Vaibhav Bhatia

founder / ceo

Our Journey

2018

Lamark Biotech Pvt. Ltd.
is established

2019

Patent - Thermostable protein
formulation technology

2022

Exclusive In-license of a Novel Molecule from Vision Institute, France

2019

Patent - Thermostable protein
formulation technology

2023-2024

Patent - Novel Insulin formulation
Patent - A novel hydrogel

Our Focus

Lamark strives to be a global pioneer in breaking cold chain dependence for Insulin and other life-saving therapeutics. By doing so, we ensure that life-saving treatments are not only available but accessible, driving a future where modern medicines are within reach for all.
Cold Chain Independence
Global
Accessibility
Sustainable Healthcare Model

Our Culture

Creating medicines for the world through global collaboration

our team

Global Minds, Unified Mission

Vaibhav Bhatia (Ph.D.)

CEO

Luis A D Cienfuegos (Ph.D.)

Director R&D

Jose A. Gavira (Ph.D.)

CSO

our global presence

OUR ASSOCIATES

We are actively collaborating with prestigious companies, research labs, and market research experts to drive innovation. Lamark Biotech will conduct R&D activities at Venture Center, NCL Innovation Park, Pune. Our strategic partnerships include Inqognito, our market research partner in India, as well as the Andalusian Initiative for Advanced Therapies (IATA) in Spain for cGMP production and clinical studies.

As a B2B company, we are forging alliances with pharmaceutical companies for API manufacturing, clinical trials, and market expansion. Together, we aim to make our flagship product – Instrong, a refrigeration-independent insulin, available in every pharmacy worldwide by 2030.